BGF leads GBP7m investment round in Phico Therapeutics
Cambridge based biotechnology company, Phico Therapeutics (Phico), has received GBP7 million in funding from a consortium of investors. BGF, the UK and Ireland’s most active growth capital investor, led the round with a GBP3 million investment, while a further GBP4 million was received from existing backers. Founded in 2000 by